FMR LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$397
-12.9%
1000.0%0.00%
Q2 2023$456
-56.6%
100
-50.0%
0.00%
Q1 2023$1,050
+112.6%
200
+100.0%
0.00%
Q4 2022$494
-50.6%
1000.0%0.00%
Q3 2022$1,0000.0%1000.0%0.00%
Q2 2022$1,0000.0%1000.0%0.00%
Q1 2022$1,0000.0%1000.0%0.00%
Q4 2021$1,0000.0%1000.0%0.00%
Q3 2021$1,0000.0%1000.0%0.00%
Q2 2021$1,0000.0%1000.0%0.00%
Q1 2021$1,0000.0%1000.0%0.00%
Q4 2020$1,0001000.0%0.00%
Q3 2020$0
-100.0%
1000.0%0.00%
Q2 2020$1,0000.0%1000.0%0.00%
Q1 2020$1,0000.0%1000.0%0.00%
Q4 2019$1,0000.0%1000.0%0.00%
Q3 2019$1,0000.0%100
-32.4%
0.00%
Q2 2019$1,000
-50.0%
1480.0%0.00%
Q1 2019$2,000
-50.0%
148
-38.3%
0.00%
Q4 2018$4,000
-33.3%
240
-19.2%
0.00%
Q3 2018$6,000
-99.7%
297
-99.7%
0.00%
Q1 2014$1,937,000
+73.4%
113,057
+48.7%
0.00%
Q4 2013$1,117,000
-12.4%
76,030
-21.0%
0.00%
Q3 2013$1,275,000
-29.8%
96,231
-43.0%
0.00%
Q2 2013$1,815,000168,9560.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders